Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma

• Main Authors: Kelsey Musselman (Author), Shannon Glynn (Author), Juan Miguel Mosquera (Author), Olivier Elemento (Author), Andrea Sboner (Author), Himisha Beltran (Author), Kevin Holcomb (Author)
• Formato: Livro
• Publicado em: Elsevier, 2019-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Uterine serous adenocarcinoma is a rare but highly malignant form of endometrial cancer, comprising over 50% of recurrences and deaths from endometrial cancer. We report a case of a 68-year old woman with recurrent uterine serous adenocarcinoma who underwent molecular testing and genetic sequencing...